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ABSTRACT 
Drug-related overdoses are now the leading injury-related death in the USA, and many of these 
deaths are associated with illicit opioids and prescription opiate pain medication. This study uses 
multiple sources of data to examine accidental opioid overdoses across 6 years, 2010 through 
2015, in Marion County, IN, an urban jurisdiction in the USA. The primary sources of data are 
toxicology reports from the county coroner, which reveal that during this period, the most 
commonly detected opioid substance was heroin. During the study period, 918 deaths involved 
opioids, and there were significant increases in accidental overdose deaths involving both heroin 
and fentanyl. In order to disentangle the nature and source of opioid overdose deaths, we also 
examine data from Indiana’s prescription drug monitoring program and the law enforcement 
forensic services agency. Results suggest that there have been decreases in the number of opiate 
prescriptions dispensed and increases in law enforcement detection of both heroin and fentanyl. 
Consistent with recent literature, we suggest that increased regulation of prescription opiates 
reduced the likelihood of overdoses from these substances, but might have also had an iatrogenic 
effect of increasing deaths from heroin and fentanyl. We discuss several policy implications and 
recommendations for Indiana. 
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INTRODUCTION 
Drug-related overdoses in 2014 were higher than any previous year on record and are 
now the leading injury-related death in the United States.1 Many drug overdose deaths are 
associated with opioids,1 a drug category encompassing both illicit heroin and prescription opiate 
pain relievers. A 2016 report from the Centers for Disease Control (CDC) finds that, since 2000, 
there has been a 137% increase in drug overdose deaths with a 200% increase in drug overdose 
deaths involving opioids.1  
Opioid addiction has become a national health epidemic in the United States, with serious 
social and economic implications. Indiana is no exception, as the percentage of hospital 
treatment episodes in Indiana for opioid use has more than doubled since 2000; in 2013, 
Indiana’s rate of overdose fatalities, 14.4 per 100,000 citizens, ranked 17th nationally (Indiana 
ranks 16 for population).2 Previous research tracked the dramatic increase in accidental overdose 
deaths in Indiana and the United States.3, 4 However, because the Indiana State Department of 
Health (ISDH) mortality files on drug-related deaths rely on ICD-10 (International Classification 
of Diseases, 10th Revision) codes, it is not possible to obtain detailed information on the specific 
opioid substances related to the fatality, a shortcoming that has been noted in academic 
literature.5-9 Therefore, given the nature of statewide data, we are unable to extricate which 
opioid substances are most commonly related to fatal overdoses.  
Given this shortcoming in available data, we developed a collaboration with the Marion 
County, Indiana coroner’s office (MCCO) and followed earlier research designs10-15 to capture 
toxicology data on all opioid-related overdoses in Marion County, Indiana from 2010 through 
2015. Then, using data from the Indiana Scheduled Prescription Electronic Collection and 
Tracking Program (INSPECT) and the Marion County Forensic Services Agency’s (MCFSA) 
screening of drug evidence, we examine whether opioid-related overdose trends are driven by 
changes in synthetic opioid prescriptions or illicit drug markets. Drawing from these multiple 
datasets allowed us to better disentangle the nature and source of opioid overdose and provide 
policy recommendations.  
 
METHODS  
Study Population. This study focuses on Marion County, Indiana from 2010 through 
2015. Marion County is the largest county in the state, and its county seat, Indianapolis, is the 
state capital. In 2015 the population was estimated at 939,020 and was 57.3% White, 28.0% 
Black, 10.0% Hispanic or Latino, and 4.7% other race/ethnicity.16 
 
Data Sources and Classifications 
The primary source of data examined in this study comes from the MCCO, which has 
jurisdiction over cases where the decedent has died as a result of casualty or violence; has died in 
a suspicious, unusual, or unnatural manner; or has died in apparent good health or been found 
dead.17, 18 As drug overdose fatalities meet these criteria, they are within the jurisdiction of the 
MCCO. The MCCO provided us with 1,256 case numbers of persons established to have died of 
an accidental drug overdose in Marion County, Indiana between January 1, 2010 and December 
31, 2015. From this list, a team of researchers were able to collect death certificates and 
                                                          
1 In this paper we use “opioid” to refer to the entire family of natural, synthetic, and semi-synthetic opiates, but use 
“opiate” to refer to synthetic prescription opiates. 
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toxicology reports for 1,199 (95.5%) of the cases.2 A careful review of these 1,199 cases found 
918 cases (76.6%) involving an opioid. Death certificates were used to capture 
sociodemographic variables such as age, race/ethnicity, gender, and marital status. For each case 
we also reviewed the toxicology report to determine whether an opioid was present in the 
decedent’s system. We recorded the presence of several opioids: 6-monoacetylmorphine 
(heroin), morphine, codeine, oxycodone, hydrocodone, oxymorphone, hydromorphone, and 
fentanyl. One of the limitations of using toxicology data to measure the presence of opioids is the 
potential for inaccurately measuring the presence of morphine and codeine. Guidelines from 
laboratory toxicologists suggest that 6-monoacetylmorphine is the definitive test for illicit heroin. 
19 However, heroin undergoes a rapid metabolic transformation into natural opioids of morphine 
or codeine and so heroin-related toxicology reports sometimes show signs of morphine and 
codeine but not 6-monoacetylmorphine. Therefore, following previous research,20 we coded 
cases that had both morphine and codeine, but not 6-monoacetylmorphine, as heroin cases. As a 
result of this we did not double count morphine and codeine again in these cases as doing so 
would over-represent the frequency of these substances in the population. Throughout the data 
collection process, two independent reviewers coded information, and a senior reviewer 
conducted random checks for accuracy in coding.  
As the source for these various opioids could stem from licit or illicit sources, we also 
analyzed opiate prescription drug trends and drug crime lab analysis trends. We gathered data on 
prescription drug patterns from the Indiana Scheduled Prescription Electronic Collection and 
Tracking Program (INSPECT). Prescription drug monitoring programs are designed to reduce 
the abuse of prescription drugs by providing law enforcement with a tool to detect and 
investigate illegal activities.21 Since 2004, INSPECT requires that all licensed pharmacies report 
the prescription and dispensation of all Schedule II through Schedule IV drugs. Therefore, in 
theory all prescription opiates distributed via licensed pharmacies are reported.  
Finally, to capture changes in illicit drug markets and the availability of illicit drugs, we 
gathered data from the records of the Marion County Forensic Services Agency (MCFSA) which 
performs both presumptive and confirmatory analysis of substances seized by the Indianapolis 
Metropolitan Police Department (IMPD) that are suspected of containing illicit substances. 
MCFSA performs these analyses when the case involving the substances is brought to trial; the 
weight of a suspected illicit substance meets or falls just under a weight specified by state law; 
and when IMPD officers tasked with performing presumptive testing encounter problems when 
testing and/or are uncomfortable with testing the substance. While these data do not provide a 
full picture of all arrests made for possession and/or distribution of illicit opioids over this time 
period, they offer a proxy measure for changes in illicit drug use patterns. 
 
Analytic Plan 
Research suggests that high rates of opioid abuse are driven by the prescribing rates of 
these substances; 21-23 therefore, the hypothesis of this study is to asses whether changes in 
prescription opiates are associated with trends in opioid-related deaths and illicit drug detections. 
Unfortunately, we are only able to examine aggregate level data, by substance and year, on 
prescriptions and forensic detection. Therefore, our analytic approach is limited to examining 
counts and annual rates of change for each substance across all three data sources.  
 
                                                          
2 Missing data were largely due to what the MCCO referred to as a “green sheet”: cases where the decedent died in a 
hospital and the coroner’s office was not contacted, but instead the decedent went directly to the funeral home.  
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RESULTS 
Coroner’s Data  
From 2010 through 2015, we identified 1,199 accidental drug overdose fatalities for 
which we were able to locate death certificates and toxicology reports; of these, 918 cases 
contained an opioid (i.e., 6-monoacetylmorphine, morphine, codeine, oxycodone, hydrocodone, 
oxymorphone, hydromorphone, or fentanyl). Table 1 displays the sociodemographic 
characteristics for the opioid-related overdoses in our study. The average age was 39.3 years old. 
There was one case of a three-year old child and two four-year children dying from an opioid 
and so the age ranged from 3 to 76 years old. The age category with the highest rate of deaths 
was 30-39 years old at 26.6%, followed by 19-29 years old at 25.4%. Table 1 also shows that 
fatalities with an opioid present were likely to be male (66.7%), White (85.3%), and never 
married (44.8%) which is disproportionate to Marion County demographics of 49.2% male, 
57.3% White, and 39.6% married.21  
 
Table 1. Sociodemographic Characteristics of 
Opioid-Related Deaths in Marion County, Indiana, 2010-2015 
 
 
 
Table 2 displays the number of occurrences of all drug-related overdoses and overdoses 
related to each opioid, from 2010 through 2015, as well as the population adjusted rates and 
M (Range)
Age 39.3 (3-76)
Age Categories N (%)
18 and Under 14 (1.5%)
19-29 233 (25.4%)
30-39 244 (26.6%)
40-49 197 (21.5%)
50-59 180 (19.6%)
60-69 48 (5.2%)
70-79 2 (0.2%)
Sex
Male 612 (66.7%)
Female 306 (33.3%)
Race/Ethnicity
Black 115 (12.5%)
White 783 (85.3%)
Hispanic 10 (1.1%)
Other 10 (1.1%)
Marital Status
Never Married 411 (44.8%)
Married 169 (18.4%)
Divorced 211 (23.0%)
Widowed 14 (1.5%)
Unknown 113 (12.3%)
N=918
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study period rate of change. During the six-year study period, the number of overall drug 
overdoses doubled from 129 to 260. The proportion of drug overdose deaths involving an opioid 
also increased during this period. In 2010, 63.6% of all accidental drug overdoses contained an 
opioid; by 2015 this increased to 80.8%. Nearly half (46.7%) of our opioid overdose deaths had 
more than one opioid substance detected in the toxicology report. The most common opioid 
detected during the study period was heroin (6-monoacetylmorphine) which was present in 
49.6% (n=455) of the cases, followed by hydrocodone at 25.9% (n=238), hydromorphone at 
24.2% (n=222), oxycodone at 21.9% (n=201), fentanyl at 20.2% (n=185), oxymorphone at 
19.4% (n=178), morphine at 11.9% (n=109), and codeine at 1.1% (n=10).  
 
Table 2. Number and Rate of Accidental Drug Overdose Deaths 
by Opioid Substance in Marion County, Indiana, 2010-2015 
 
 
 
Figure 1. Trends in Opioid-Related Deaths by 
Substance in Marion County, Indiana, 2010-2015 
 
 
Note: Rates of change for heroin and fentanyl were statistically significant  
during the time period and are highlighted above.  
 
The far right column of Table 2 displays the rate of change over the study period for each 
opioid and shows study period increases in all of the substances except oxymorphone and 
hydromorphone. The opioids with the highest rate of annual change were heroin and fentanyl 
Rate of Change
N Rate N Rate N Rate N Rate N Rate N Rate 2010-2015
All Drug Overdoses 129 14.3 154 16.9 186 20.2 227 24.5 243 26.0 260 27.7 20.3
Any Opioid 82 9.1 111 12.2 146 15.9 165 17.8 204 21.8 210 22.4 31.2
  Heroin 22 2.4 50 5.5 82 8.9 84 9.0 106 11.3 111 11.8 80.9
  Morphine 15 1.7 19 2.1 18 2.0 21 2.3 18 1.9 18 1.9 4.0
  Codeine 1 0.1 0 0.0 2 0.2 2 0.2 1 0.1 4 0.4 60.0
  Fentanyl 15 1.7 13 1.4 11 1.2 14 1.5 69 7.4 63 6.7 64.0
  Oxycodone 23 2.5 32 3.5 37 4.0 44 4.7 36 3.9 29 3.1 5.2
  Hydrocodone 31 3.4 41 4.5 48 5.2 45 4.8 38 4.1 35 3.7 2.6
  Oxymorphone 24 2.7 29 3.2 34 3.7 42 4.5 29 3.1 20 2.1 -3.3
  Hydromorphone 28 3.1 42 4.6 48 5.2 38 4.1 41 4.4 25 2.7 -2.1
Notes: Categories are not mutuallyexclusive. Rate is per 100,000 residents.
2010 20152014201320122011
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with an 80.9% and 64.0% increase, respectively. The number of cases with heroin increased 
from 22 in 2010 to 111 in 2015, while fentanyl increased from 15 in 2010 to 63 in 2015. These 
two substances largely contributed to the 31.2% annual increase in the number of opioid-related 
deaths, which increased from 82 deaths in 2010 to 210 deaths in 2015. Figure 1 illustrates the 
trends among all the substances in light gray but highlights heroin and fentanyl, which had the 
largest rates of change over the study period.   
 
Prescription Data 
In order to examine what might be driving changes in overdose patterns, we next turn to 
county-level data from INSPECT. For these data we examined seven of the same substances 
from the toxicology reports which included morphine, codeine, fentanyl, oxycodone, 
hydrocodone, oxymorphone, and hydromorphone. Table 3 shows the number of prescriptions 
dispensed by substance. At an average of over 1.5 million prescriptions per year, the most 
frequently prescribed opiate in Indiana was hydrocodone. In 2010 it was the most common 
opioid found in toxicology reports, more than heroin and fentanyl combined, and during the 
entire study period, it was detected in 238 overdose deaths. The next most commonly prescribed 
opiate was oxycodone, which averaged 450,312 prescriptions per year. It is worth noting that 
while the number of oxycodone prescriptions were less than a third of hydrocodone, the 
difference in deaths associated with oxycodone did not feature this difference. Following 
oxycodone, the next highest average opiate prescriptions were morphine (86,743), codeine 
(83,404), fentanyl (51,001), hydromorphone (16,503), and oxymorphone (9,885). As shown in 
Table 3, with the exception of oxycodone, all of the prescription opiates have reductions in the 
number of prescriptions dispensed over the six-year period.  
 
Table 3. Prescriptions Dispensed by Opiate 
Substance in Marion County, Indiana, 2010-2015 
  
 
 
Figure 2 uses the values from Table 3 to display trends in the number of prescriptions for 
each of the opiates. In order to illustratively compare the substances, the numbers are relative to 
each substance; however, what Figure 2 shows is that nearly all of the substances had decreases 
following a peak in prescriptions. For each substance there is a vertical gray line showing the 
year 2012. Four of the seven substances—hydromorphone, morphine, oxycodone, and 
hydrocodone—saw large increases from 2010 through 2012. For example, hydromorphone had a 
31.1% increase from 2010 to 2012, followed by oxycodone with a 19.3% increase, morphine 
with a 17.4% increase, and hydrocodone with a 9.8% increase. The remaining substances—
codeine, fentanyl, and oxymorphone—all had only moderate decreases during this time. 
However, all seven of the substances had decreases in prescriptions from 2012 to 2013; codeine 
decreased by 18.4%, fentanyl by 10.7%, hydrocodone by 9.8%, oxymorphone by 6.0%, 
Rate of Change
Prescription Opiate 2010 2011 2012 2013 2014 2015 2010-2015
Morphine 83,451 89,187 97,979 92,471 79,609 77,763 -1.5
Codeine 88,420 93,016 84,765 69,196 83,626 81,403 -1.7
Fentanyl 57,969 56,596 56,707 50,663 43,928 40,144 -8.9
Oxycodone 418,782 442,842 499,663 478,774 425,247 436,565 0.8
Hydrocodone 1,669,451 1,704,825 1,833,542 1,653,940 1,414,155 1,283,887 -6.0
Oxymorphone 10,009 11,577 9,942 9,342 9,360 9,077 -2.1
Hydromorphone 14,764 16,628 19,353 18,487 15,614 14,172 -0.8
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morphine by 5.6%, hydromorphone by 4.5%, and oxycodone by 4.2%. With the exception of 
codeine (which has 20.9% increase from 2013 to 2014) and oxymorphone (which only increased 
by 0.2%) all of the substances had even more dramatic decreases from 2013 to 2014.  
 
Figure 2. Trends in Opiate Prescriptions in Marion County, Indiana, 2010-2015 
 
 
 
Law Enforcement Data 
The final source of data we examined came from the MCFSA’s (Marion County Forensic 
Services Agency) screening of drug evidence from all public safety agencies in Marion County. 
Again we looked at the same opioid substances analyzed in the coroner and INSPECT data, in 
the same county, over the same six-year time period. There were 9,122 positive screens for these 
eight opioids (6-monoacetylmorphine, morphine, codeine, oxycodone, hydrocodone, 
oxymorphone, hydromorphone, or fentanyl). At 5,209 detections, the substance detected most 
often during the six-year period was heroin; however, as shown in Table 4, this was partially due 
to a large annual increase during the period as heroin detections increased threefold from 452 in 
2010 to 1,520 in 2015. Moreover, while heroin consistently had the highest number of detections 
among these substances, in 2010 heroin detections were only slightly above hydrocodone (452 
and 429 respectively), though as heroin has increased, hydrocodone has decreased from 429 
detections in 2010 to 235 in 2015.  
 
Table 4. Law Enforcement Detections of Opioid 
Substances in Marion County, Indiana, 2010-2015 
 
 
 
Table 4 shows the highest annual increase was in fentanyl, with an average of 6 
detections from 2010 through 2013 increasing to 54 in 2014 and 60 in 2015. The timing of the 
Rate of Change
Opioid Substance 2010 2011 2012 2013 2014 2015 2010-2015
Heroin 452 526 764 1,056 891 1,520 47.3
Morphine 54 36 68 46 21 42 -4.4
Codeine 13 14 14 16 9 14 1.5
Fentanyl 4 7 2 9 54 60 280.0
Oxycodone 143 183 248 269 207 347 28.5
Hydrocodone 429 392 401 298 201 235 -9.0
Oxymorphone 2 4 4 18 8 4 20.0
Hydromorphone 8 4 11 11 0 3 -12.5
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fentanyl increases in MCFSA detections are consistent with overdose patterns which show an 
average of 13.3 deaths from 2010 through 2013 and a sharp increase to 69 deaths in 2014 and 63 
deaths in 2015 (see Table 2). Figure 3 shows trends with fentanyl among all three data sources in 
this study. Overdose and law enforcement data followed a similar trend, detecting more fentanyl 
which is represented by values on the left Y-axis; however, these increases corresponded to 
decreases in prescription fentanyl over this same time period which are represented by values on 
the right Y-axis. That is, as prescriptions of fentanyl began to decrease in 2012 and 2013 there 
were increases in overdose deaths and law enforcement detections of the fentanyl.  
 
Figure 3. Fentanyl Trends in Marion County, Indiana, 2010-2015 
 
Note: Left Y-axis represents overdose and law enforcement counts and right  
Y-axis represents prescription counts. 
 
Discussion 
 This study examined death certificate and toxicology data from 2010 through 2015 that 
were collected in collaboration with the coroner’s office. We examined trends in these data and 
then used prescription drug monitoring and forensic data from local police in an attempt to better 
understand these trends. Consistent with national trends, we found increases in the overall 
number of drug-related death and that these increases were largely driven by opioids.4 Using data 
collected from toxicology reports, we were able to examine the specific opioid-related 
substances detected in these deaths. Heroin and fentanyl were the substances with the highest 
annual increases in accidental overdose fatalities during the study period. In 2010, Marion 
County drug overdose deaths were more likely to include prescription opiates; however, by 2015 
the number of deaths related to heroin were nearly equivalent to the number of deaths related to 
all these substances combined. Consistent with the literature on drug and opioid-related 
overdoses, we found that polydrug intoxication was common.24-26 Unfortunately, we were unable 
to collect data on all licit and illicit substances that might interact with opioids for this study; 
notably missing are benzodiazepines, a substance that is often found in conjunction with opioids 
in overdoses.27, 28 Given space limitations we did not include a full analysis of polydrug 
interactions though generally speaking we found a higher degree of polydrug presence among 
the prescription opiates that illicit opioids; however, in looking at the presence of a singular 
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opioid, we found that these substances, in particular heroin and fentanyl, were those most 
commonly found alone.  
In order to help explain trends in opioid-related deaths, we turned to prescription drug 
monitoring data and forensic data collected from law enforcement. Looking at INSPECT data 
over time we found consistent decreases in prescription opiates from 2010 to 2015 with a notable 
decline following 2012; fentanyl was the substance with the greatest decline. In examining the 
MCFSA data we found a pattern in heroin and fentanyl that closely mirrored the coroner’s 
toxicology data. Specifically, we found rates of heroin detection more than tripled; fentanyl, 
which was only present in 4 cases in 2010, increased to 60 detections by 2015. Unfortunately, 
given the aggregated nature of these datasets, beyond this we were unable to observe and 
determine an association with deaths. 
In interpreting these results, some limitations should be kept in mind. This study was 
constrained by our reliance on multiple sources of administrative data. With the coroner’s data 
we were limited in the years for which electronic death certificates were available as well as the 
substances that we could reliably code for over this period. INSPECT, data are highly protected, 
and only after considerable efforts were we able to obtain data on specific substances. Even then 
the data were presented only prescriptions (not dispensations) at aggregated levels and with no 
identifiable or demographic information. Future research should consider addressing these 
protective barriers and focus on ways to examine more detailed INSPECT data and how to link 
these data other individual-level data. For example, with more detailed data on the prescription—
such as the date of the prescription and dispensation as well as the number of pills and 
milligrams—we could more precisely examine when policy changes took effect and how these 
had an impact on prescribing behaviors. MCFSA data are also only aggregated and are not linked 
to demographics and case characteristics. Moreover, individuals can be charged with illicit 
opioid possession and/or distribution for very small to very large amounts, so the presence of 
these substances does not indicate the actual amount of illicit opioids available. Therefore, these 
forensic data might be a more accurate reflection of law enforcement patterns than illicit drug 
market activity. Also all of the data are limited over time (2010 to 2015) and geographically 
(Marion County, Indiana). It is likely that deaths of Marion County residents occurred in other 
counties and that prescription and illicit drugs associated with deaths were procured outside of 
the county. Yet, in spite of these limitations, this study offers important insight into opioid 
overdoses. Specifically, our findings are consistent with a growing body of research suggesting 
that while increased regulation of prescription opiates can reduce the likelihood of these 
substances to be present in overdoses,29-31 it also results in nonmedical prescription opiate 
users—those using prescription opiates, without a prescription, for the purposes of experiencing 
or feeling the effects of the drug—turning to illicit opioids.32-35  
 
Conclusion and Policy Recommendations 
A post-hoc analysis of the three data sets suggests a trend in Marion County that is 
consistent with recent analysis of drug use patterns; as prescription opiates become unavailable, 
users are turning to illicit opioids.33-35 The dramatic increase in prescription opiates during the 
1990s and 2000s is well documented and is generally attributed to greater social acceptance, 
diversification in what these drugs are used for, and marketing activities of pharmaceutical 
companies.36, 37 Our Table 3 shows the decline in prescriptions for codeine and oxymorphone is 
evident as of 2012 whereas the decline in prescriptions for all other opioids is not present until 
2013. The timing of the reduction in prescription opiates in Indiana is likely due to two pieces of 
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legislation—Senate Enrolled Act 246 and House Enrolled Act 1465—both of which were 
introduced in January 2013 and signed into law in April 2013.38, 39 Senate Enrolled Act 246 was 
aimed at shutting down “pill mills” by requiring that clinics apply to the Indiana Controlled 
Substances Registration which would grant them permission to prescribe scheduled substances. 
The second piece of legislation, House Enrolled Act 1465, provided funding for INSPECT that 
allowed prescribers, dispensers, and law enforcement to access prescribing history but also set 
forth new protocols and standards for prescribing controlled substances. For example, physicians 
prescribing for chronic pain were required to obtain, review, and document records from prior 
providers; use validated screening tools; and follow prescribing thresholds. The Medical 
Licensing Board of Indiana adopted these rules in 2013. Moreover, this legislation also 
established the “Bitter Pill” initiative and website which focused on educating the public about 
the dangers of abusing prescription drugs and how to report illegal activities. In short, the 
INSPECT data analyzed in this study suggests that these legislative efforts were successful in 
reducing the number of controlled substances prescribed. In addition to legislation there were 
other factors that likely contributed to declines in illicit prescription drugs in Indiana. For 
example, there were several high-profile, multi-site, high-volume Indiana “pill mills” that were 
shut down by the Drug Enforcement Administration (DEA) as well as nationwide “take-back” 
initiatives began in 2010 as part of the Secure and Responsible Drug Disposal Act of 2010.40-42 
Thus the combination of DEA shutdowns of Indiana pill mills, nationwide take back initiatives 
as a result of the 2010 Secure and Responsible Drug Disposal Act of 2010 and the 
aforementioned pieces of 2013 legislation likely all contributed to declines in access to at least 
initially licitly obtained opiates. 
Indiana’s prescription drug monitoring regulation may have had an iatrogenic effect on 
users and thus rates of fatal overdose from heroin and fentanyl. However, deregulation of 
prescription opiates is certainly not a solution to overdose and evidence suggests that increased 
law enforcement efforts are not likely have a major impact either. In fact, more aggressive 
policing policies have been show to increase rates of incarceration and thereby the risk of 
overdose.43-45 The clear policy recommendation for Indiana is to expand treatment: Indiana has 
only 14 Opioid Treatment Programs (OTPs); in comparison, neighboring Midwest states such as 
Illinois have 71 OTP facilities, Ohio has 21, and Michigan has 34.46 The low number is partially 
the result of a 2008 moratorium on approving new OTPs which has resulted in many users 
having to wait or be denied services.47 The lack of treatment options in Indiana has not only 
resulted in increased rates of death but also infectious diseases. In 2015 Indiana made national 
headlines when an HIV outbreak was reported in Scott County with the majority of infections 
linked to needle sharing for the purposes of injecting prescription opioids.48 Prior to this 
outbreak, neighboring states adopted syringe exchange programs while Indiana maintained a 
ban.49 In short, INSPECT has been effective in reducing the distribution of nonmedical 
prescription drugs and, based on this study, might also have had a moderate impact on the rate of 
fatal overdoses associated with these substances. However, policies regarding the availability 
and funding of evidence-based treatments have lagged behind and likely play a role in the rates 
of overdose found in this study and others which suggest nonmedical prescription drug use and 
overdose in Indiana are higher than national rates.4, 50  
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